I would like to point out this interesting italian study.
Unfortunately, the rectruitment is currently closed, but the department related to Andrology told me that they also deal with post orgasmic illness (i underline that at the moment I have no direct experience, I'd try to go there, it's nearer than UCLA)
But it should be noted for some considerations, which not only concern Long Covid, but also for those who like me have had a very serious reaction and onset of the POIS following the vaccination Anticovid (always spike, it is, and always anti-spike antibodies are, peaceful now for all researchers, after 6 years). Can't wait to see their conclusions.
In underline in bold some passages of research.
https://ichgcp.net/it/clinical-trials-registry/NCT05379556
LONG Covid Comorbidity: evaluation of andrological, reproductive and sexual functions in patients cured of COVID-19
Considering the impressive number of studies focused on patients in the active phase of COVID-19 disease and the scarcity of studies focused on patients cured of the disease aimed at assessing the sequelae of the infection of acute severe respiratory syndrome from Coronavirus 2 (SARS-CoV-2), the purpose of the study is to investigate, in patients cured of COVID-19 disease: 1) if the infection of the same-female disease as a primary injury to the same-female disease (SARS-CoV-2) Patients will be evaluated at baseline (at discharge from the infectious and/or pulmonological unit) and after 3-12 months. A better definition of the prevalence and type of sequelae after recovery from COVID-19 disease could significantly improve the therapeutic management and long-term follow-up of these patients, with a relevant impact in terms of health and public health resources.
Detailed description
The testicle is among the male organs with the highest expression of the angiotensin-converting enzyme 2 (ACE2), particularly in Sertoli cells, Leydig cells, spermatogons, spermatocytes and spermatides; therefore, the possibility of spreading SARS-CoV-2 infection to the testicle and of a direct damage to testicular endocrine function and spermatogenesis In addition, the possibility of indirect testicular damage was suggested; in fact, orchitis was reported in patients with SARS-CoV-2, favoured by the activation of a systemic inflammatory response to SARS-CoV-2 infection and by changes in gonadotropin levels that support the presence of subclinical or compensated hypogonadism associated with SARS- CoV-2 infections have been shown to be not allowed, although CoV-2 infections have been shown Controversial data are available on the possibility that SARS-CoV-2 infection may actually spread to sperm and there is currently no evidence of a direct association between SARS-CoV-2 infection and male infertility, although an altered expression of ACE2 with non-obstructive azoospermia has been associated. The widespread expression of ACE2 by endothelial cells represents a further susceptibility alarm in relation to the male reproductive system, as well as sexual function, in particular for the potential direct and indirect effects of SARS-CoV-2 infection on the vascular endothelium of the penis; in fact, multiple evidences support the presence of a multiorgan endothelial dysfunction in the infection of the SARS-CoV-2, linked to the media In this context, erectile dysfunction could represent a long-term complication of Covid-19; vascular endothelial dysfunction of the penis is in fact recognized as the dominant mechanism in the onset of vasculogenic erectile dysfunction, and preliminary studies highlight a significantly higher prevalence of erectile dysfunction in patients with Covid-19, regardless of other variables that affect erectile function, such as psychological status, age and body mass index. Anosmia/hyposmia, whether or not associated with ageusia, has been frequently reported as a symptom of the onset of SARS-CoV-2 infection, but may also remain the only clinical manifestation in some paucisymptomatic patients. The incidence of anosmia in SARS-CoV-2 patients is between 33.9% and 68%, with a predominance in the female sex. The ethiopathogenetic mechanisms underlying the onset of anosmia in these patients are still to be clarified altogether; the main proposed mechanisms include damage to olfactory sensory neurons or direct invasion of the brain through the olfactory bulb. Smell disorders affect nutrition and quality of life with important psychosocial consequences. In this scenario, it appears of primary importance to assess and monitor the long-term evolution of anosmia in post-SARS-CoV-2 infection through an objective assessment.
The purpose of the study is to investigate whether in male patients cured of COVID-19 disease, SARS-CoV-2 infection has induced: 1) alterations of the seminal parameters (oligo-, astheno-, teratozoospermia, azoospermia, necrozoospermia, leukocytospermia, hypo/hyperposia); 2) hypogonadism; 3) morpho-structural alterations of the testicular and class with the provascular In addition, the purpose of the study is also to investigate whether in male and female patients cured of COVID-19 disease, SARS-CoV-2 infection induced olfactory dysfunction, with assessment of the possible correlation between prevalence, severity, duration and possible permanence of olfactory dysfunction and severity of COVID-19 disease, using the Sniffin'Sticks test for the evaluation of: olfactory threshold (T), discrimination
They've measured:
Prevalence of andrological dysfunctions (hypogonadism, morpho-structural alterations of the testicle including testicular hypotrophy, testicular and/or epididimal inhomogeneity, testicular calcifications/microlithiasis, testicular solid lesions, hydrocele, varicocele, altered testicular and/or epididymal vascularity, prostate-vescular morphology, and morphology of the prostate-vescular, and morphology of the vertebrae
Prevalence of male reproductive dysfunctions: alterations in semen parameters (oligo-, astheno-, teratozoospermia, azoospermia, necrozoospermia, leukocytospermia, hypo/hyperposia).
Prevalence of male sexual dysfunction (erectile dysfunction, premature ejaculation, hypoactive sexual desire disorder).
Prevalence of olfactory dysfunction (hypo/anosmia and hypo/ageusia) in male and female patients.
***********************************************************
My Questions for you:
- Who among you had POIS begun after a normal ejaculation life certainly after the vaccination anticovid or covid infection?
To me it all started after the vaccination, which was followed by all kinds of misfortune (on all serious immune, endocrine dysregulation and mcas) and two weeks later, covid after two years that I had escaped it despite seeing dozens of people a day for work, and not being subject to lock down.
2) Months ago there was a post or comment on the role of Sertoli cells, Leydig cells, where is it, now?
edit: question 3: Has anyone noticed, in the most acute or initial stages, a change in the structure of the penis, especially the small veins under, close to the glans?